Anti-HER2 monoclonal antibody linked to the microtubule inhibitor MMAE. After binding HER2 on tumor cells, the ADC is internalized and the linker is cleaved to release MMAE, which disrupts microtubules causing cell-cycle arrest and apoptosis; the membrane-permeable payload can produce a bystander effect.